By G HossainPosted on June 8, 2026Posted in Pharmaceutical & Bio Science, UncategorizedTagged bio science career, blogs, business career news, career tips, job blog, job news, RJF Pharmaceutical Jobs Roche and Nurix Therapeutics will advance their BTK degrader for chronic lymphocytic leukemia, as well as immunology and neurology indications. Roche makes up to $3B blood cancer play with Nurix’s protein degrader Post navigation ADA: Kailera ‘back at work’ after record-breaking IPO with China data in handIncyte’s stars align as new CEO strikes $2B Vega takeover for blood disorder asset